Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance. (2021)
Attributed to:
Defining the microenvironmental contexture of the biopsy-naive, MRI-characterized prostate.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bju.15136
PubMed Identifier: 32531869
Publication URI: http://europepmc.org/abstract/MED/32531869
Type: Journal Article/Review
Volume: 127
Parent Publication: BJU international
Issue: 1
ISSN: 1464-4096